Trip Do’s and Don’ts: What to Avoid During Your Psychedelic Experience
If you are going on a psychedelic trip, you must be aware of what to avoid while tripping to avoid a bad trip and maximize the experience.
lsd
Unlocking Creativity: How Acid Transformed My Artistic Journey
Does acid have the power to unlock creativity? It did for this artist. Read their story about how acid helped with their artistic expression.
Beyond the Hourglass: Duration, Expectations, and Integration of an Acid Trip
This article informs on how long an acid trip lasts, what affects its duration, and how to navigate through each stage of the trip.
A “Trip-Less” Alternative? Non-Hallucinogenic LSD Analog Shows Promise for Treating Mood Disorders
A non-hallucinogenic LSD analogue may be able to treat mood disorders and chronic stress without the hallucinations.
Want to Try Psychedelics in a Clinical Setting? 116 Trials Now Recruiting Volunteers (UPDATED)
Here’s how to become a research subject for psilocybin, LSD, MDMA, ibogaine, DMT and 5-MeO-DMT studies.
Uncovering the Mysteries of LSD: New Study Examines How it Alters Brain Connections
A new study published in the Journal of Psychopharmacology investigating LSD’s effects on the brain reveals interesting findings.
Shrooms vs. LSD: Differences, Similarities & Research Progress
A direct comparison between the subjective effects, onset time, mystical experience and research of shrooms vs. LSD.
The Biggest Psychedelic News Stories of This Week – April 28
Some of the biggest psychedelic news this week include the Colorado Senate passing a bill to regulate psychedelics.
Phase II Study Shows LSD Is Effective In Treating Major Depressive Disorder
Data from a Phase 2 clinical trial involving LSD-assisted psychotherapy show LSD as effective treatment for Major Depressive Disorder.
Can You Combine Psychedelics and Antidepressants? A Dive into Potential Interactions and Safety
Is it safe to mix psychedelics and antidepressants like SSRIs? In this article, we look at the research to assess the potential risks.
End of content
End of content